Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.880
+0.050 (2.73%)
Feb 19, 2026, 2:27 PM EST - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $72.31 million as of February 19, 2026. Its market cap has increased by 26.21% in one year.
Market Cap
72.31M
Enterprise Value
62.18M
1-Year Change
26.21%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $72.31M, a decrease of -41.99%. That is a compound annual growth rate of -10.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 70.39M | -43.17% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 74.09M |
| XBiotech | 73.16M |
| Adicet Bio | 71.15M |
| NovaBay Pharmaceuticals | 70.54M |
| ImageneBio | 69.76M |
| Pliant Therapeutics | 69.44M |
| TuHURA Biosciences | 68.61M |
| Coeptis Therapeutics Holdings | 68.16M |